Tag: BMRN

Finance

Stay on: CalAmp Corp. (NASDAQ:CAMP), Exelon Corporation (NYSE:EXC), Hewlett-Packard Company (NYSE:HPQ), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), QUALCOMM, Inc. (NASDAQ:QCOM)

CalAmp (NASDAQ: CAMP), reported results for its third quarter ended November 30, 2014. Consolidated third quarter revenue up 7% sequentially to $63.2 million and essentially flat year over year. CalAmp Corp. (NASDAQ:CAMP) belongs to Technology sector. Its net profit margin is 5.50% and weekly performance is -9.77%. On last trading day company shares ended up $17.74. CalAmp Corp. (NASDAQ:CAMP) distance from 50-day simple moving average … Continue reading Stay on: CalAmp Corp. (NASDAQ:CAMP), Exelon Corporation (NYSE:EXC), Hewlett-Packard Company (NYSE:HPQ), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), QUALCOMM, Inc. (NASDAQ:QCOM)

Harvey Dyer
Finance

Top News : Nokia Corporation (ADR) (NYSE:NOK), Starbucks Corporation (NASDAQ:SBUX), BlackRock Kelso Capital Corporation (NASDAQ:BKCC), BMRN, First Clover Leaf Financial Corp. (NASDAQ:FCLF)

On October 27, Moody’s Investors Service has changed to positive from stable the outlook on the Ba2 corporate family rating (CFR) of Nokia Corporation (ADR) (NYSE:NOK), following the company’s stronger-than-expected results for the first nine months of 2014, as well as the upward revision to slightly above 11% from 5%-10% of its guidance for 2014 operating margins. Nokia Corporation (ADR) (NYSE:NOK) belongs to Technology sector. … Continue reading Top News : Nokia Corporation (ADR) (NYSE:NOK), Starbucks Corporation (NASDAQ:SBUX), BlackRock Kelso Capital Corporation (NASDAQ:BKCC), BMRN, First Clover Leaf Financial Corp. (NASDAQ:FCLF)

Adam Keintzel
Finance

Stocks In News: Dollar General Corp. (NYSE:DG), Arcos Dorados Holding Inc (NYSE:ARCO), WisdomTree Investments, Inc. (NASDAQ:WETF), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Dollar General Corp. (NYSE:DG), a rival chain, has said it’s not interested in a merger with Family Dollar. And Wal-Mart wouldn’t have much use for the company’s stores because they’re too small for its Express format, Montagna said. Dollar General Corp. (NYSE:DG) stock performance was 7.35% in last session and finished the day at $62.25. Traded volume was 25.42million shares in the last session and … Continue reading Stocks In News: Dollar General Corp. (NYSE:DG), Arcos Dorados Holding Inc (NYSE:ARCO), WisdomTree Investments, Inc. (NASDAQ:WETF), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Jayne Crisman
Finance

Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Shares of ImmunoGen Inc. (NASDAQ:IMGN), a biopharmaceutical company focused on developing therapies to fight cancer, advanced as much as 15% after research firm Canaccord Genuity initiated coverage on the company. ImmunoGen, Inc. (NASDAQ:IMGN) stock performance was 11.02% in last session and finished the day at $14.21. Traded volume was 2.85million shares in the last session and the average volume of the stock remained 858.46K shares. … Continue reading Biotech bullish Stocks: ImmunoGen (NASDAQ:IMGN), OXiGENE Inc (NASDAQ:OXGN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics (NASDAQ:CLDX)

Jayne Crisman
Finance

Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and AstraZeneca (NYSE:AZN) are among those companies with late stage drugs in trials that specifically target genetic mutations. Both BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s BMN-673, which is in phase 3 trials, and Astra’s Olaparib, which may get the EU’s go-ahead in ovarian cancer this year, address a mutation of the BRCA 1 and BRCA 2 gene that is often associated with breast … Continue reading Biotech Losers: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Celldex Therapeutics, Inc. (NASDAQ:CLDX), Novavax, Inc. (NASDAQ:NVAX), Biogen Idec Inc (NASDAQ:BIIB)

Jayne Crisman